Serocode

Bengaluru, India Founded: 2022 • Age: 4 yrs
Platform offering tools for early detection of chronic diseases
Annual revenue - Latest available
Total funding - Funding intelligence
Employees 1 Tracked headcount
Investors - Known backers
Products 1 Services tracked
Competitors 11 Brand Intelligence

About Serocode

Serocode is a company based in Bengaluru (India) founded in 2022. The company has 1 employees as of March 29, 2024. Serocode offers products and services including Predictive Diagnostic Platform. Serocode operates in a competitive market with competitors including C the Signs, inveox, Nanovery, Inspirata and FireGen Biomedicals, among others.

  • Headquarter Bengaluru, India
  • Employees 1 as on 29 Mar, 2024
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Legal Name Serocode Biolabs Private Limited
  • Date of Incorporation 14 Nov, 2022
  • Jurisdiction Bangalore, Karnataka, India
Operational Areas
Healthcare → Health Technology & Digital Health Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    1

    as on Mar 29, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Serocode

Serocode offers a comprehensive portfolio of products and services, including Predictive Diagnostic Platform.

Product name locked
Category locked
Primary

Platform for early detection of chronic diseases via blood tests.

Funding Insights of Serocode

Premium access

Detailed funding history for Serocode

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Serocode

Investments
Premium access

Investment portfolio details for Serocode

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Serocode

Premium access

Detailed financials for Serocode

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Serocode Comparisons

Serocode Primary company
Description
Platform offering tools for early detection of chronic disea...
Location
Bengaluru, India
Founded Year
2022
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
1
As of 2024
Premium access

Peer comparison for Serocode

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Serocode

Serocode operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as C the Signs, inveox, Nanovery, Inspirata and FireGen Biomedicals, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Platform offering cancer prediction system for early cancer detection
Locked Locked Locked
Automated solutions for biopsy sample preparation in laboratories are provided.
Locked Locked Locked
Nanobots are developed for cancer diagnosis through bloodstream administration.
Locked Locked Locked
Digital pathology solutions for cancer diagnostics are developed by Inspirata.
Locked Locked Locked
Digital molecular testing tools for disease diagnosis
Locked Locked Locked
Developer of cloud-based imaging and sample management platform
Premium access

Detailed competitors of Serocode

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Serocode

Premium access

Complete news archive for Serocode

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Serocode

Serocode was founded in 2022.

Serocode is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.

As of Mar 29, 2024, the latest employee count at Serocode is 1.

Serocode was founded in 2022 in Bengaluru, India, as a health technology platform focused on preventive diagnostics. Blood tests are offered for early identification of conditions such as atherosclerosis, type 2 diabetes, neurodegeneration, prostate cancer, gastrointestinal cancer, male infertility, and autism spectrum disorder. Operations center on providing accessible screening solutions in the chronic disease management sector.

Serocode's top competitors include inveox, C the Signs and Nanovery.

Serocode offers Predictive Diagnostic Platform.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available